Meredith A Mills
Overview
Explore the profile of Meredith A Mills including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guha T, Esplin E, Horning A, Chiu R, Paul K, Weimer A, et al.
bioRxiv
. 2024 Nov;
PMID: 39605357
Colorectal cancer (CRC) is the third leading cause of cancer mortality in the United States. Familial adenomatous polyposis (FAP) is a hereditary syndrome that raises the risk of developing CRC,...
2.
Esplin E, Hanson C, Wu S, Horning A, Barapour N, Nevins S, et al.
Nat Cancer
. 2024 Oct;
5(11):1737-1753.
PMID: 39478120
Familial adenomatous polyposis (FAP) is a genetic disease causing hundreds of premalignant polyps in affected persons and is an ideal model to study transitions of early precancer states to colorectal...
3.
Almeda A, Grimes S, Lee H, Greer S, Shin G, McNamara M, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Jun;
31(9):1693-1700.
PMID: 35771165
Background: Gastric cancer is a leading cause of cancer morbidity and mortality. Developing information systems which integrate clinical and genomic data may accelerate discoveries to improve cancer prevention, detection, and...
4.
Hall E, Parikh D, Caswell-Jin J, Gupta T, Mills M, Kingham K, et al.
JCO Precis Oncol
. 2022 Feb;
2:1-10.
PMID: 35135157
Purpose: As genetic testing expands, patients are increasingly found to carry pathogenic variants in cancer susceptibility genes that are less familiar to most clinicians, specifically genes other than those causing...
5.
Idos G, Kurian A, Ricker C, Sturgeon D, Culver J, Kingham K, et al.
JCO Precis Oncol
. 2021 Jul;
3.
PMID: 34322651
Purpose: Multiplex gene panel testing (MGPT) allows for the simultaneous analysis of germline cancer susceptibility genes. This study describes the diagnostic yield and patient experiences of MGPT in diverse populations....
6.
Culver J, Ricker C, Bonner J, Kidd J, Sturgeon D, Hodan R, et al.
Cancer
. 2020 Dec;
127(8):1275-1285.
PMID: 33320347
Background: Little is known about the psychological outcomes of germline multigene panel testing, particularly among diverse patients and those with moderate-risk pathogenic variants (PVs). Methods: Study participants (N = 1264)...
7.
Ricker C, Koff R, Qu C, Culver J, Sturgeon D, Kingham K, et al.
Transl Behav Med
. 2018 Feb;
8(1):85-94.
PMID: 29385580
Research on the communication of genetic test results has focused predominately on non-Hispanic White (NHW) mutation-positive families with high-risk hereditary cancer conditions. Little is known about this process for racially...
8.
Caswell-Jin J, Gupta T, Hall E, Petrovchich I, Mills M, Kingham K, et al.
Genet Med
. 2017 Jul;
20(2):234-239.
PMID: 28749474
PurposeWe examined racial/ethnic differences in the usage and results of germ-line multiple-gene sequencing (MGS) panels to evaluate hereditary cancer risk.MethodsWe collected genetic testing results and clinical information from 1,483 patients...
9.
Desmond A, Kurian A, Gabree M, Mills M, Anderson M, Kobayashi Y, et al.
JAMA Oncol
. 2015 Aug;
1(7):943-51.
PMID: 26270727
Importance: The practice of genetic testing for hereditary breast and/or ovarian cancer (HBOC) is rapidly evolving owing to the recent introduction of multigene panels. While these tests may identify 40%...
10.
Lincoln S, Kobayashi Y, Anderson M, Yang S, Desmond A, Mills M, et al.
J Mol Diagn
. 2015 Jul;
17(5):533-44.
PMID: 26207792
Gene panels for hereditary breast and ovarian cancer risk assessment are gaining acceptance, even though the clinical utility of these panels is not yet fully defined. Technical questions remain, however,...